Frontlight ResearchEarly access
Childhood cancers trials in United Kingdom
158 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Multi-Arm, Platform Trial For Relapsed Neuroblastoma
- Where
- Aberdeen, Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leeds, Liverpool, London, Manchester, Newcastle upon Tyne, Nottingham, Oxford, Sheffield, Southampton, Sutton
- Age
- 1 year to 64 years
- People
- 160 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT07334301 · EU 2024-516115-24-00 - No phaseTaking peopleA Real-world Data and Sample Compendium of Frail and/or Multiply Treated Large B-cell Lymphoma
- Where
- Liverpool
- Age
- 17 years and over
- People
- 800
- Run by
- The Clatterbridge Cancer Centre NHS Foundation Trust
See details and how to joinNCT07335120 - No phaseTaking peopleInternational Leukemia Target Board
- Where
- Newcastle
- Age
- 0 years to 25 years
- People
- 600 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05270096 - Phase 1Taking peopleAnti-CCR9 CAR T Cells for T Cell Leukaemia/Lymphoma
- Where
- London
- People
- 24
- Run by
- University College, London
See details and how to joinNCT07300683 - No phaseNot yet taking people in United KingdomInvestigation of the ROle of faT and inflAmmaTory Cells in mElanoma
- Where
- Manchester
- People
- 20
- Run by
- The Christie NHS Foundation Trust
See details and how to joinNCT07293598 - Phase 2/3Taking peopleDETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
- Where
- Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leicester, Liverpool, London, Manchester, Metropolitan Borough of Wirral, Newcastle, Oxford, Sheffield, Southampton, Sutton
- Age
- 12 years and over
- People
- 30
- Run by
- Cancer Research UK
See details and how to joinNCT05786716 - Phase 2/3Taking peopleDETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
- Where
- Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leicester, Liverpool, London, Manchester, Metropolitan Borough of Wirral, Newcastle, Oxford, Sheffield, Southampton, Sutton
- People
- 30
- Run by
- Cancer Research UK
See details and how to joinNCT05770037 - Phase 2/3Taking peopleDETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
- Where
- Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leicester, Liverpool, London, Manchester, Metropolitan Borough of Wirral, Newcastle, Oxford, Sheffield, Southampton, Sutton
- People
- 30
- Run by
- Cancer Research UK
See details and how to joinNCT05770102 - Phase 2/3Taking peopleDETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
- Where
- Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leicester, Liverpool, London, Manchester, Metropolitan Borough of Wirral, Newcastle, Oxford, Sheffield, Southampton, Sutton
- People
- 30
- Run by
- Cancer Research UK
See details and how to joinNCT05770544 - No phaseTaking peopleCryopreservation of Prepubertal Testicular Tissue for Preservation of Fertility in Young Boys With Cancer
- Where
- Edinburgh
- Age
- 1 day to 18 years
- People
- 100
- Run by
- University of Edinburgh
See details and how to joinNCT06063551 - No phaseTaking peopleID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
- Where
- Birmingham
- People
- 2,000 worldwide
- Run by
- Stanford University
See details and how to joinNCT02848274 - No phaseTaking peopleAI-Driven Early Detection of Skin Cancer
- Where
- London
- Age
- 18 months and over
- People
- 100
- Run by
- Nuvana Healthcare LTD
See details and how to joinNCT07144306 - Phase 1/2Not yet taking people in United KingdomHEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
- Where
- Bristol, London, Manchester, Newcastle, Sutton
- Age
- 1 year to 21 years
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05658640 · EU 2022-501869-41-00 - Phase 1/2Not yet taking people in United KingdomHEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Bristol, London, Newcastle, Sutton
- Age
- 1 year to 21 years
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05745714 · EU 2022-501867-42-01 - Phase 1/2Not yet taking people in United KingdomHEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Bristol, London, Newcastle, Sutton
- Age
- 1 year to 21 years
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05751044 · EU 2022-501866-22-00 - No phaseCompletedAPACE - Feasibility of Using Accelerometers to Measure Physical Activity in Cancer Patients on Early Phase Clinical Trials
- Where
- Leicester, Manchester
- Age
- 16 years and over
- People
- 40 worldwide
- Run by
- University of Manchester
See details and how to joinNCT06868355 - No phaseTaking peopleSalutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and Safety
- Where
- London
- People
- 40
- Run by
- Salutare Group Ltd.
See details and how to joinNCT07104955 - No phaseTaking peopleA Platform Study for solId orgaN CancERs
- Where
- Liverpool
- Age
- 16 years to 100 years
- People
- 2,000
- Run by
- University of Liverpool
See details and how to joinNCT05650125 - Phase 1/2Taking peopleA Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
- Where
- Birmingham, Cambridge, Leeds, London, Manchester, Sutton
- Age
- 16 years and over
- People
- 84
- Run by
- Cancer Research UK
See details and how to joinNCT06045910 - Phase 2Not yet taking people in United KingdomSarcoma Surgery Wound Complications Comparing Usual Versus Negative Pressure Dressing
- Where
- Glasgow
- Age
- 16 years and over
- People
- 94
- Run by
- NHS Greater Glasgow and Clyde
See details and how to joinNCT07048184 - No phaseNot yet taking people in United KingdomImproving Diagnosis and Treatment for Patients With Rectal Cancer
- Where
- Oxford, Salisbury, Southampton
- Age
- 16 years to 99 years
- People
- 438
- Run by
- Imperial College London
See details and how to joinNCT07054047 - Phase 3Taking peopleHigh-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
- Where
- Aberdeen, Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leeds, Liverpool, London, Manchester, Newcastle, Nottingham, Sheffield, Southampton, Sutton
- Age
- Up to 21 years
- People
- 800 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04221035 · EU 2024-514917-36-00 - No phaseEnrolling by invitationInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Birmingham, Edinburgh
- Age
- 1 day and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906 - No phaseTaking peopleTransforming Ovarian Cancer Diagnostic Pathways
- Where
- Birmingham, Gateshead, Wolverhampton
- People
- 34,000
- Run by
- Professor Sudha Sundar
See details and how to joinNCT06129968 - Phase 2Taking peopleA Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- Where
- London, Newcastle upon Tyne
- Age
- 6 months to 25 years
- People
- 141 worldwide
- Run by
- Day One Biopharmaceuticals, Inc.
See details and how to joinNCT04775485 · EU 2024-510691-20-00